Bioelectronics Corp (BIEL)

[Simpsonly]

Thanks very much for the good work fuente
A classic case of 'no news is good news'

As I have said before, the FDA has no interest whatsoever in harming BIEL or its investors. Just the opposite, its only interest is in helping the American public and it does an excellent job of that.

Patience is the key. In my view, it is unimaginable that the FDA will return a negative result on ActiPatch and ALLAY, given that BIEL already has FDA approval of its RecoveryRx device for post-op eye surgery use (that would be over the eye area and near the brain in a human, post-op?) and the advances in PEMF I've read about. No side-effects, no harm, no chemicals - what drug manufacturer can say that.....

I would like to know how many samples of ALLAY have been sent to the FDA for in-house testing by its female employees.... that would be a very cool clinical trial!